This inventor holds 4 USPTO granted patents and 7 published patent applications. Top assignee: Oncocross Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yi Rang Kim: Innovator in Predictive Modeling for Compound-Protein Interactions
Introduction
Yi Rang Kim is a prominent inventor based in Sejong, South Korea. He has made significant contributions to the field of predictive modeling, particularly in understanding the interactions between compounds and proteins. With a total of 4 patents to his name, Kim is recognized for his innovative approaches in this area.
Latest Patents
Kim's latest patents include a method, apparatus, and computer program for predicting the interaction of compounds and proteins. This invention provides a systematic approach to predicting interactions by acquiring learning data composed of compound data, protein data, and interaction scores. The method involves constructing a deep-learning model that accurately predicts interactions by excluding amino acid sequences that negatively influence these interactions. Another patent focuses on a similar methodology, emphasizing the importance of training data and the deep-learning model's ability to predict interactions in an in vivo environment.
Career Highlights
Yi Rang Kim is currently employed at Oncocross Co., Ltd., where he continues to develop innovative solutions in the field of biotechnology. His work is instrumental in advancing the understanding of compound-protein interactions, which has significant implications for drug development and therapeutic applications.
Collaborations
Kim collaborates with notable colleagues, including Jin Woo Choi and Sang Yun Park, who contribute to his research and development efforts. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Yi Rang Kim is a key figure in the realm of predictive modeling for compound-protein interactions. His patents and ongoing work at Oncocross Co., Ltd. reflect his commitment to advancing biotechnology and improving drug discovery processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile